• OPEN AN ACCOUNT
Indian Indices
Sensex
76,957.27 -307.24
( -0.40%)
Global Indices
Nasdaq
53,569.16 -21.28
(-0.04%)
Dow Jones
7,731.77 -20.22
(-0.26%)
Hang Seng
66,147.06 -258.50
(-0.39%)
Nikkei 225
10,824.26 31.76
(0.29%)
Forex
USD-INR
95.48 0.22
(0.23%)
EUR-INR
111.24 0.16
(0.15%)
GBP-INR
129.74 0.04
(0.03%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
144.69
460696.31
EPS(TTM)
Face Value()
Div & Yield %
13.27
1
0.83
 

future consumer enterprise ltd
Stanrose Mafatlal Investment & Finance reports consolidated net loss of Rs 0.89 crore in the March 2026 quarter
May 19,2026
Net Loss of Stanrose Mafatlal Investment & Finance reported to Rs 0.89 crore in the quarter ended March 2026 as against net loss of Rs 0.89 crore during the previous quarter ended March 2025. Sales reported to Rs 1.72 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 3.02 crore in the year ended March 2026 as against net loss of Rs 2.26 crore during the previous year ended March 2025. Sales rose 109.56% to Rs 2.85 crore in the year ended March 2026 as against Rs 1.36 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1.720 0 2.851.36 110
OPM %-40.700 --89.82-130.88 -
PBDT-0.70-0.77 9 -2.57-1.80 -43
PBT-0.86-0.88 2 -3.12-2.25 -39
NP-0.89-0.89 0 -3.02-2.26 -34